Pathogenic role of platelets in rheumatoid arthritis and systemic autoimmune diseases

References

1. ↵
   1. Davı` G,
   2. Patrono C

   (2007) Platelet activation and atherothrombosis. N Engl J Med 357:2482–2494.

   OpenUrlCrossRefPubMedWeb of Science
2. 1. Semple JW,
   2. Freedman J

   (2010) Platelets and innate immunity. Cell Mol Life Sci 67:499–511.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Smith TL,
   2. Weyrich AS

   (2011) Platelets as central mediators of systemic inflammatory responses. Thromb Res 127:391–394.

   OpenUrlCrossRefPubMed
4. ↵
   1. Boilard E,
   2. Nigrovic PA,
   3. Larabee K,
   4. Watts GF,
   5. Coblyn JS,
   6. Weinblatt ME,
   7. et al.

   (2010) Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327:580–583.

   OpenUrlAbstract/FREE Full Text
5. ↵
   1. Lam FW,
   2. Vijayan KV,
   3. Rumbaut RE

   (2015) Platelets and their interactions with other immune cells. Compr Physiol 5:1265–1280.

   OpenUrl
6. ↵
   1. Nurden AT

   (2011) Platelets, inflammation and tissue regeneration. Thromb Haemost 105(Suppl 1):S13–S33.

   OpenUrlCrossRefPubMed
7. ↵
   1. Esmon CT

   (2008) Crosstalk between inflammation and thrombosis. Maturitas 61:122–131.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   1. Weyrich AS,
   2. Lindemann S,
   3. Zimmerman GA

   (2003) Review. The evolving role of platelets in inflammation. J Thromb Haemost 1:1897–1905.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Smith TL,
   2. Weyrich AS

   (2011) Platelets as central mediators of systemic inflammatory responses. Thromb Res 127:391–394.

   OpenUrlCrossRefPubMed
10. ↵
    1. Kaplan MJ,
    2. Radic M

    (2012) Neutrophil extracellular traps (NETs): Double-edged swords of innate immunity. J Immunol 189:2689–2695.

    OpenUrlAbstract/FREE Full Text
11. ↵
    1. Ma AC,
    2. Kubes P

    (2008) Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis. J Thromb Haemost 6:415–420.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    1. Franco AT,
    2. Corken A,
    3. Ware J

    (2015) Platelets at the interface of thrombosis, inflammation, and cancer. Blood 126:582–588.

    OpenUrlAbstract/FREE Full Text
13. ↵
    1. Baumgartner HR

    (1977) Platelet interaction with collagen fibrils in flowing blood, I: reaction of human platelets with alpha chymotrypsin-digested subendothelium. Thromb Haemost 37:1–16.

    OpenUrlPubMedWeb of Science
14. ↵
    1. Nieswandt B,
    2. Watson SP

    (2003) Platelet-collagen interaction: is GPVI the central receptor? Blood 102:449–461.

    OpenUrlAbstract/FREE Full Text
15. ↵
    1. Hsu J,
    2. Gu Y,
    3. Tan SL,
    4. Narula S,
    5. DeMartino JA,
    6. Liao C

    (2013) Bruton’s Tyrosine Kinase mediates platelet receptor-induced generation of microparticles: a potential mechanism for amplification of inflammatory responses in rheumatoid arthritis synovial joints. Immunol Lett 150:97–104.

    OpenUrlCrossRefPubMed
16. ↵
    1. Knijff-Dutmer EA,
    2. Koerts J,
    3. Nieuwland R,
    4. Kalsbeek-Batenburg EM,
    5. van de Laar MA

    (2002) Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum 46:1498–1503.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    1. Zimmerman GA,
    2. Weyrich AS

    (2010) Immunology. Arsonists in rheumatoid arthritis. Science 327:528–529.

    OpenUrlAbstract/FREE Full Text
18. ↵
    1. Bunescu A,
    2. Seideman P,
    3. Lenkei R,
    4. Levin K,
    5. Egberg N

    (2004) Enhanced Fcg receptor I, aMb2 integrin receptor expression by monocytes and neutrophils in rheumatoid arthritis: interaction with platelets. J Rheumatol 31:2347–2355.

    OpenUrlAbstract/FREE Full Text
19. ↵
    1. Boilard E,
    2. Blanco P,
    3. Nigrovic PA

    (2012) Platelets: active players in the pathogenesis of arthritis and SLE. Nat Rev Rheumatol 8:534–542.

    OpenUrlCrossRefPubMed
20. ↵
    1. Cloutier N,
    2. Paré A,
    3. Farndale RW,
    4. Schumacher HR,
    5. Nigrovic PA,
    6. Lacroix S,
    7. et al.

    (2012) Platelets can enhance vascular permeability. Blood 120:1334–1343.

    OpenUrlAbstract/FREE Full Text
21. ↵
    1. Boilard E,
    2. Larabee K,
    3. Shnayder R,
    4. Jacobs K,
    5. Farndale RW,
    6. Ware J,
    7. et al.

    (2011) Platelets participate in synovitis via Cox-1-dependent synthesis of prostacyclin independently of microparticle generation. J Immunol 186:4361–4316.

    OpenUrlAbstract/FREE Full Text
22. ↵
    1. Habets KL,
    2. Trouw LA,
    3. Levarht EW,
    4. Korporaal SJ,
    5. Habets PA,
    6. de Groot P,
    7. et al.

    (2015) Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis. Arthritis Res Ther 17:209.

    OpenUrlCrossRefPubMed
23. ↵
    1. Lood C,
    2. Eriksson S,
    3. Gullstrand B,
    4. Jonsen A,
    5. Sturfelt G,
    6. Truedsson L,
    7. et al.

    (2012) Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus - a possible link to venous thrombosis? Lupus 21:1423–1432.

    OpenUrlCrossRefPubMedWeb of Science
24. ↵
    1. Navratil JS,
    2. Manzi S,
    3. Kao AH,
    4. Krishnaswami S,
    5. Liu CC,
    6. Ruffing MJ,
    7. et al.

    (2006) Platelet C4d is highly specific for systemic lupus erythematosus. Arthritis Rheum 54:670–674.

    OpenUrlCrossRefPubMedWeb of Science
25. ↵
    1. Gasparyan AY,
    2. Stavropoulos-Kalinoglou A,
    3. Mikhailidis DP,
    4. Toms TE,
    5. Douglas KM,
    6. Kitas GD

    (2010) The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 8:437–449.

    OpenUrlCrossRefPubMedWeb of Science
26. ↵
    1. Antoniades C,
    2. Bakogiannis C,
    3. Tousoulis D,
    4. Antonopoulos AS,
    5. Stefanadis C

    (2009) The CD40/CD40 Ligand system: linking inflammation with atherothrombosis. J Am Coll Cardiol 54:699–677.

    OpenUrl
27. ↵
    1. Desai-Mehta A,
    2. Lu L,
    3. Ramsey-Goldman R,
    4. Datta SK

    (1996) Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 97:2063–2073.

    OpenUrlCrossRefPubMedWeb of Science
28. ↵
    1. Duffau P,
    2. Seneschal J,
    3. Nicco C,
    4. Richez C,
    5. Lazaro E,
    6. Douchet I,
    7. et al.

    (2010) Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus. Sci Transl Med 2:47ra63.

    OpenUrlAbstract/FREE Full Text
29. ↵
    1. Ferreira GA,
    2. Navarro TP,
    3. Telles RW,
    4. Andrade LE,
    5. Sato EI

    (2007) Atorvastatin therapy im-proves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial. Rheumatology (Oxford) 46:1560–1565.

    OpenUrlCrossRefPubMedWeb of Science
30. ↵
    1. Dhar JP,
    2. Andersen J,
    3. Essenmacher L,
    4. Ager J,
    5. Bentley G,
    6. Sokol RJ,
    7. et al.

    (2009) Thrombophilic patterns of coagulation factors in lupus. Lupus 18:400–406.

    OpenUrlCrossRefPubMedWeb of Science
31. ↵
    1. Dees C,
    2. Akhmetshina A,
    3. Zerr P,
    4. Reich N,
    5. Palumbo K,
    6. Horn A,
    7. et al.

    (2011) Platelet-derived serotonin links vascular disease and tissue fibrosis. J Exp Med 208:961–972.

    OpenUrlAbstract/FREE Full Text
32. ↵
    1. Postlethwaite AE,
    2. Chiang TM

    (2007) Platelet contributions to the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 19:574–579.

    OpenUrlCrossRefPubMedWeb of Science
33. ↵
    1. Maugeri N,
    2. Franchini S,
    3. Campana L,
    4. Baldini M,
    5. Ramirez GA,
    6. Sabbadini MG,
    7. et al.

    (2012) Circulating platelets as a source of the damage associated molecular pattern HMGB1 in patients with systemic sclerosis. Autoimmunity 45:584–587.

    OpenUrlCrossRefPubMed
34. ↵
    1. Mannucci PM,
    2. Lombardi R,
    3. Lattuada A,
    4. Perticucci E,
    5. Valsecchi R,
    6. Remuzzi G

    (1989) Supranormal von Willebrand factor multimers in scleroderma. Blood 73:1586–1591.

    OpenUrlAbstract/FREE Full Text
35. ↵
    1. Chiang TM,
    2. Takayama H,
    3. Postlethwaite AE

    (2006) Increase in platelet nonintegrin type I collagen receptor in patients with systemic sclerosis. Thromb Res 117:299–306.

    OpenUrlCrossRefPubMed
36. ↵
    1. Belch JJ,
    2. O’Dowd A,
    3. Forbes CD,
    4. Sturrock RD

    (1985) Platelet sensitivity to a prostacyclin analogue in systemic sclerosis. Br J Rheumatol 24:346–350.

    OpenUrlCrossRefPubMed
37. ↵
    1. Habets KL,
    2. Huizinga TW,
    3. Toes RE

    (2013) Platelets and autoimmunity. Eur J Clin Invest 43:746–757.

    OpenUrlCrossRefPubMed
38. ↵
    1. Kisacik B,
    2. Tufan A,
    3. Kalyoncu U,
    4. Karadag O,
    5. Akdogan A,
    6. Ozturk MA,
    7. et al.

    (2008) Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 75:291–294.

    OpenUrlCrossRefPubMedWeb of Science
39. ↵
    1. Yazici S,
    2. Yazici M,
    3. Erer B,
    4. Erer B,
    5. Calik Y,
    6. Ozhan H,
    7. et al.

    (2010) The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets 21:122–125.

    OpenUrlCrossRefPubMedWeb of Science
40. ↵
    1. Yazici S,
    2. Yazici M,
    3. Erer B,
    4. Erer B,
    5. Calik Y,
    6. Bulur S,
    7. et al.

    (2010) The platelet functions in patients with ankylosing spondylitis: anti-TNF-alpha therapy decreases the mean platelet volume and platelet mass. Platelets 21:126–131.

    OpenUrlCrossRefPubMedWeb of Science
41. ↵
    1. Canpolat F,
    2. Akpinar H,
    3. Eskioğlu F

    (2010) Mean platelet volume in psoriasis and psoriatic arthritis. Clin Rheumatol 29:325–328.

    OpenUrlCrossRefPubMed
42. ↵
    1. Sellam J,
    2. Proulle V,
    3. Jüngel A,
    4. Ittah M,
    5. Miceli Richard C,
    6. Gottenberg JE,
    7. et al.

    (2009) In-creased levels of circulating microparticles in primary Sjögren’s syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther 11:R156.

    OpenUrlCrossRefPubMed
43. ↵
    1. Sarac H,
    2. Markeljevic J,
    3. Mokrovic G,
    4. Erdeljic V,
    5. Bozina N,
    6. Cicin-Sain L

    (2012) Platelet serotonin in primary Sjögren’s syndrome: level and relation with disease activity. J Neuro Immunol 251:87–89.

    OpenUrl
44. ↵
    1. Karabudak O,
    2. Nalbant S,
    3. Sahan B,
    4. Unal M,
    5. Ersanli D

    (2008) Mean platelet volume in Behçet’s disease. Akt Rheumatol 33:217–220.

    OpenUrl
45. ↵
    1. Acikgoz N,
    2. Karincaoglu Y,
    3. Ermis N,
    4. Yagmur J,
    5. Atas H,
    6. Kurtoglu E,
    7. et al.

    (2010) Increased mean platelet volume in Behçet’s disease with thrombotic tendency. Tohoku J Exp Med 221:119–123.

    OpenUrlCrossRefPubMed
46. ↵
    1. Coban E,
    2. Adanir H

    (2008) Platelet activation in patients with Familial Mediterranean Fever. Platelets 19:405–408.

    OpenUrlCrossRefPubMedWeb of Science
47. ↵
    1. Sahin S,
    2. Senel S,
    3. Ataseven H,
    4. Yalcin I

    (2013) Does mean platelet volume influence the attack or attack-free period in the patients with Familial Mediterranean fever? Platelets 24:320–323.

    OpenUrl
48. ↵
    1. Gasparyan AY,
    2. Ayvazyan L,
    3. Mikhailidis DP,
    4. Kitas GD

    (2011) Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 17:47–58.

    OpenUrlCrossRefPubMed
49. ↵
    1. Balbaloglu O,
    2. Korkmaz M,
    3. Yolcu S,
    4. Karaaslan F,
    5. Beceren NG

    (2014) Evaluation of mean platelet volume (MPV) levels in patients with synovitis associated with knee osteoarthritis. Platelets 25:81–85.

    OpenUrlCrossRefPubMed
50. ↵
    1. Langer HF,
    2. Gawaz M

    (2008) Platelet-vessel wall interactions in atherosclerotic disease. Thromb Haemost 99:480–486.

    OpenUrlPubMed
51. ↵
    1. Von Hundelshausen P,
    2. Weber C

    (2007) Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 100:27–40.

    OpenUrlAbstract/FREE Full Text
52. ↵
    1. Scheuerer B,
    2. Ernst M,
    3. Durrbaum-Landmann I,
    4. Fleischer J,
    5. Grage-Griebenow E,
    6. Brandt E,
    7. et al.

    (2000) The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood 95:1158–1166.

    OpenUrlAbstract/FREE Full Text
53. ↵
    1. Massberg S,
    2. Brand K,
    3. Grüner S,
    4. Page S,
    5. Müller E,
    6. Müller I,
    7. et al.

    (2002) A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 196:887–896.

    OpenUrlAbstract/FREE Full Text
54. ↵
    1. Gasparyan AY,
    2. Stavropoulos-Kalinoglou A,
    3. Mikhailidis DP,
    4. Douglas KM,
    5. Kitas GD

    (2011) Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int 31:153–164.

    OpenUrlCrossRefPubMed
55. ↵
    1. Chu SG,
    2. Becker RC,
    3. Berger PB,
    4. Bhatt DL,
    5. Eikelboom JW,
    6. Konkle B,
    7. et al.

    (2010) Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 8:148–156.

    OpenUrlCrossRefPubMedWeb of Science
56. ↵
    1. Gasparyan AY,
    2. Stavropoulos-Kalinoglou A,
    3. Toms TE,
    4. Douglas KM,
    5. Kitas GD

    (2010) Association of mean platelet volume with hypertension in rheumatoid arthritis. Inflamm Allergy Drug Targets 9:45–50.

    OpenUrlCrossRefPubMedWeb of Science
57. ↵
    1. Boulman N,
    2. Rozenbaum M,
    3. Slobodin G,
    4. Rosner I

    (2005) Acute polyarthritis associated with clopidogrel treatment. Isr Med Assoc J 7:670–671.

    OpenUrlPubMed
58. ↵
    1. Tayyareci Y

    (2008) Acute arthritis associated with loading dose of clopidogrel. J Clin Rheumatol 14:254–255.

    OpenUrlPubMed
59. ↵
    1. Aksu K,
    2. Donmez A,
    3. Keser G

    (2012) Inflammation-induced thrombosis: mechanisms, disease associations and management. Curr Pharm Des 18:1478–1493.

    OpenUrlCrossRefPubMed
60. ↵
    1. Mertens M,
    2. Singh JA

    (2009) Anakinra for rheumatoid arthritis. Cochrane Database Syst Rev (1):CD005121.